Product Information

PITAVASTATIN 1 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.9977 per EA under NDC 68382048116. Its NADAC has been published 131 times since Feb 21, 2024.

FDA first approved this application on Feb 22, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PITAVASTATIN 1 MG TABLET

pitavastatin calcium
$0.9977per EA

Strength

1 mg/1

NDC

68382048116

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

PITAVASTATIN CALCIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA206047

FDA Approved

2/22/2023

TE Code

AB

On Market Since

11/2/2023

Pharmacological Classes

HMG-CoA Reductase Inhibitor
Hydroxymethylglutaryl-CoA Reductase Inhibitors

Price Statistics

The NADAC for PITAVASTATIN 1 MG TABLET has been published 131 times since Feb 21, 2024, and over the history we have for it it has declined 56.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.9977 per EA
All-time high$2.3862 (Apr 10, 2024)
All-time low$0.9977 (Aug 19, 2026)
52-week high$1.6105
52-week low$0.9977
Median price$1.5698
Average price$1.6288
Largest weekly change+23.0% (Jun 19, 2024)
Weeks tracked131
Tracking sinceFeb 21, 2024

Price History

1W

-12.1%

1M

-12.1%

3M

-16.8%

6M

-17.9%

1Y

-36.4%

3Y

N/A

5Y

N/A

All

-56.8%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the pitavastatin calcium market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of PITAVASTATIN 1 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for PITAVASTATIN 1 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.9977 per EA (NDC 68382048116), effective Aug 19, 2026.

How has the price of PITAVASTATIN 1 MG TABLET changed over time?

Over the history we have for it, the NADAC for PITAVASTATIN 1 MG TABLET has declined 56.8%. It has been tracked across 131 weekly CMS publications since Feb 21, 2024.

What are the highest and lowest recorded NADAC prices for PITAVASTATIN 1 MG TABLET?

Since Feb 21, 2024, the NADAC for PITAVASTATIN 1 MG TABLET has ranged from a low of $0.9977 (Aug 19, 2026) to a high of $2.3862 (Apr 10, 2024), with a median of $1.5698 per EA.

Are there cheaper alternatives to PITAVASTATIN 1 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of PITAVASTATIN 1 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures PITAVASTATIN 1 MG TABLET?

PITAVASTATIN 1 MG TABLET (NDC 68382048116) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.